Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News 22nd PKPD Expertentreffen in the heart of the Black Forest 3rd GBHI in Amsterdam: lively discussions and intensive exchange with authorities Meet us in Amsterdam: 3rd GBHI Conference starts soon (12 – 13 April 2018) Meet us in Munich: AGAH Annual Meeting 26 – 27 April 2018 Regorafenib: first in human as eye drops 3rd GBHI conference – all speakers confirmed Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
Pulse oximetry plethysmography Pragmatism Biopharmaceutical Clinical study Paediatricians CDISC Ophthalmology Absorption Standard operating procedure Protocol development Standardisation Training Pilot study CRO Project Management Biometrics Recruitment rates Phase I Clinical Monitoring Statistical Analysis Plan Non interventional Intensive assessment station Expert TTS Pharmacology Patch adhesion Patch Steady state Consultancy Monitoring Pharmacokintetics Informed Consent Procedure IB AGAH Oncological patients Quality Assurance Sore throat PASS Subcontractor qualification Axis Oncologic network CDASH Ophthalmological trials MCID ANVISA Phase IIb trials Clinical development program IVIVC Edema Healthy subjects Quality Management System Experience DFI Data Validation Plan Biosimilars Pituitary CRF Lung Inspection HPA axis HRT Hormone replacement therapy Patients SDV First in human COPD Statistical services Data management Highly variable drugs Phase III Competence Clinical pharmacology unit CDSIC Audit Cardiovascular surveillance Early phase SOP based Quality Dry powder inhaler Thuringia Good Clinical Practice Efficacy Transdermal therapeutic system GLP WinNonlin IEC CDM Scientific advice Eye disease Common cold Phase I Unit Adrenocortical Children Dose linearity Postmenopausal women Source Data Verification Network Phase IIa trials Local tolerability Database Patient recruitment Contraception Biopharmaceutics DPI Life cycle management SocraTec C&S Anaesthesiologist Charcoal Oncology Metered dose inhaler EMA Allergy Female adolescents Pharmacodynamic studies Glaucoma Ophthalmologist FIM Macular Centralised procedure ICF Asthma Bioequivalence Dermal irritation Phase II US FDA Hypothalamic CRA Central surveillance system Immunogenicity Statistical programming Sensitisation trials Inhalatives Design development Safety Elpro Slit lamp microscopy Protocol Auditing In vitro in vivo correlation HTA DDI Uveitis Drug Drug Interaction DUS Data Management Plan Ocular tolerability Absorption windows Pharmacokinetics Ovulation inhibition Bioavailability Degeneration Creativity Clinical trials Rhine Main area GCP NIS Referral system Gynaecological trials Post authorisation Sample size estimation FDA OTC Cough Xerostomia Legal Information Endpoint Authorities Drug Food Interaction PAES ADAM Copyright Scientific expertise Dry eye MDI Feasibility GCP training Spacious archive Sequential designs Legal representative Investigators brochure SAS MMM Product development IMPD Phase IV US CFR 21 Part 11  
 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on front page